Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RHOA | P61586 | 1/20 | 0.55 |
| ▸ | EGFR | P00533 | 13/20 | 0.49 |
| ▸ | ITK | Q08881 | 5/20 | 0.49 |
| ▸ | BTK | Q06187 | 7/20 | 0.47 |
| ▸ | KCNH3 | Q9ULD8 | 2/20 | 0.45 |
| ▸ | IDH2 | P48735 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22356444 | 1.00 | RHOA (0.55) | RHOAEGFRITKBTKKCNH3 | |
| SCHEMBL22356453 | 0.96 | EGFR (0.48) | RHOAEGFRITKBTKKCNH3 | |
| SCHEMBL22356445 | 0.94 | RHOA (0.49) | RHOAEGFRITKBTKMEN1 | |
| SCHEMBL22356391 | 0.90 | RHOA (0.54) | RHOAEGFRITKBTKIDH2 | |
| SCHEMBL22356433 | 0.90 | RHOA (0.54) | RHOAEGFRITKBTKIDH2 | |
| SCHEMBL22356455 | 0.89 | SYK (0.46) | RHOAEGFRITKKCNH3KMT2A | |
| SCHEMBL22356441 | 0.89 | SYK (0.46) | RHOAEGFRITKKCNH3KMT2A | |
| SCHEMBL22356381 | 0.89 | RHOA (0.51) | RHOAEGFRITKBTKKCNH3 | |
| SCHEMBL22356392 | 0.87 | RHOA (0.49) | RHOAEGFRITKBTK | |
| SCHEMBL22356482 | 0.87 | MAPT (0.51) | RHOAEGFRITKBTKKCNH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200262798-A1 | NOVEL TRIAZINE DERIVATIVE AND PHOTOSENSITIVE COMPOSITION COMPRISING SAME | TREEEL CO., LTD (KR) | 2020-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200262798-A1 | NOVEL TRIAZINE DERIVATIVE AND PHOTOSENSITIVE COMPOSITION COMPRISING SAME | TYR, CRY2, CRY1 | RHOA 3916/4885EGFR 2575/4885ITK 1348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.